THE famous names of the lecturers who have given the Scott-Heron Lecture before me, the weight of their subjects and the breadth of the areas of the world from which they were drawn, ensure two things in any subsequent lecturer -a sense of awe and a sense of apprehension. Both these sensations are mine, but I have had the temerity to accept your wonderful invitation because they are subject to others -to the honour you have done me, and my pleasure at it.
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I have been told I can talk of a special interest in the clinical field, and I have chosen systemic lupus erythematosus (S.L.E.). This condition is to me a fascinating one. It used to be said that all medicine could be learnt from the study of syphilis, and most acute medicine from patients with typhoid, and this is now very nearly true for systemic lupus erythematosus. I do not pretend, of course, that systemic lupus erythematosus is a common condition, but it is not a rare one, and as our knowledge of its clinical manifestations has increased in the last 25 and even 10 years, so it is more frequently recognised. My personal records, and those of others, lead me to believe that rheumatoid arthritis is about eight times commoner than systemic lupus erythematosus, and that systemic lupus erythematosus is three times commoner than scleroderma, polyarteritis nodosa or cranial arteritis, and six times commoner than dermatomyositis. Although I have claimed that it has been recently much better understood, I must admit that much of clinical interest was recognised by our medical forebears before the turn of the last century and subsequently largely forgotten.
Discussion of the nature of systemic lupus erythematosus has for some time centred largely around the possibility of a disorder of immunity, and in particular of auto-immunity, but the aetiology is still unknown. There are, however, other factors upon which speculations can be based. The frequency with which this condition affects women during the child-bearing period naturally suggests that the sex hormones play an important part, but although the high mortality rate corresponds suggestively to the levels of urinary oestrogen excretion, endocrine factors cannot be the whole story as both men and women of all ages can be affected .
There is increasing evidence that genetic factors are of importance, both from case histories showing a familial incidence, and from experimental observations, for example, in the mice NZB (Burnet, 1965) and there are seven reports of S.L.E. in identical twins, in one of which it was accompanied by multiple sclerosis in both twins (Holmes et al., 1967) . The report by Leonhardt (1967) is notable as he records a family of 14 siblings, 3 of whom had S.L.E. associated with hypergammaglobulinaemia, a fourth had hypergammaglobulinaemia and 4 more had raised serum globulin levels without any clinical manifestations.
The precipitating effect of certain drugs has some relevance here. Support for the well established belief that hydralazine acts as a precipitant comes from a study of fifty patients with the syndrome (Alarcon-Segovia et al., 1964) An acute onset -An acute onset, with fever, wasting and often with skin lesions, occurs in about 20 per cent. of patients, and of these over half will be dead within three years. The diagnosis will quickly be established if L.E. cells are found early on in the illness, but this is far from being invariably the case, and patients are seen in whom they are only found once, and then in small numbers, or even in whom they are never found although widespread histological changes are present at autopsy.
Fever occurs in almost 100 per cent. of patients with an acute onset, and in 85 per cent. of all cases. Skin lesions are seen in about 70 per cent. of patients who are acutely ill, and in half of all patients at the onset. Arthralgia may be a presenting feature in these patients (20 per cent.), but is more commonly seen when the onset is insidious (75 per cent.). Acute renal lesions may occur at the onset, and when they do they usually carry with them a bad prognosis. Blood disorders, such as thrombocytopenic purpura or an acute acquired haemolytic anaemia, are sometimes early features of an acute onset.
A computer analysis of 520 patients by Dubois (1964) has shown that certain combinations of clinical features are commonly observed. Arthralgia, fever, nephropathy and anaemia were present in 30 per cent. of this large series, and arthralgia, fever, adenopathy and pleurisy in 29.6 per cent. S.L.E. may, however, present in a score of ways, and an interesting manner is when recurrent incidents of, for example, pleurisy, pericarditis, mental symptoms and fits, precede the establishment of true diagnosis.
Fever -Fever at the onset may be insignificant relative to the other symptoms and the degree of illness of the patient. It may, on the other hand, be the sole feature, when it may be high swinging, or sustained, the patient presenting as a problem in diagnosis. Recurrent febrile periods accompany activity of the disease process, and often mirror its degree, but at times patients are seen who are surprisingly free from other symptoms, or even feel reasonably well with a persistent fever of about 101°.
SKIN LESIONS IN SYSTEMIC LuPus ERYTHEMATOSUS
The skin lesions of lupus erythematosus, including the chronic discoid type, are common when compared with the rarer disorder of systemic lupus erythematosus. They are chiefly confined to the head, including the face, scalp, lips and mucous membranes. They are precipitated by exposure to sunlight and by cold. They may leave unsightly scars from atrophy of the skin and telangiectasia, but not infrequently there is little or no residual disfigurement.
When systemic lupus erythematosus is present the skin may be unaffected or only minimally so, with patchy erythema on the extremities, notably the backs of the fingers and toes, but also on the trunk. The rash may, however, be very extensive, involving in particular a butterfly area over the nose and cheeks, areas much exposed to sunlight. Apart from the erythema, from which the disorder takes part of its name, purpura can occur with or without thrombocytopenia. Swellings of the extremities, with colour and temperature changes and sometimes leg ulcers, which can in some instances be due to cryoglobulinaemia (Larson, 1961) are not infrequent features.
ARTHRITIS AND ARTHRALGIA I have already stressed the high incidence of joint pains during the course of the disease. The pains may be severe in some patients even when there are few accom-panying signs, such as swelling and local tenderness. The knees are most frequently the source of pain, but other joints can also be affected.
Joint changes may resemble in appearance those of rheumatoid arthritis, and sometimes there is an overlap between systemic lupus erythematosus and rheumatoid arthritis. The joints may, however, have somewhat negative features; they are not always symmetrically involved and the degree of destruction seen radiologically can be less than might have been expected from the severity of the symptoms. The muscles round them waste, not only from disuse but also from a polymyositis, which is a feature of the condition.
SUBCUTANEOUS NODULES These may occur on the extensor surfaces, closely resembling those of rheumatoid arthritis clinically and histologically, with central necrosis and palisade of cells, or rarely the nodules may be due to relapsing nodular non-suppurative panniculitis without subsequent atrophy.
THE CARDIOVASCULAR SYSTEM Peripheral vessels -Peripheral vascular lesions are commonly seen in patients with discoid and with systemic lupus erythematosus, and Raynaud's phenomenon can pre-date other symptoms by many years. Hutchinson's pernio, also known as lupus pernio or chilblain lupus, is a classical manifestation. The patients may have had chilblains for many years, usually with Raynaud-like colour changes, and their fingers may be scarred by healed recurrent ulceration. Again, cryoproteins and cryoprecipitation may be demonstrated.
Venous thromboses can occur at the onset as well as during the course of the disease. They can be recurring or migratory, and thus systemic lupus erythematosus should be considered as a possible cause of unexplained thrombosis and of thrombophlebitis migrans. The great vessels from the heart are occasionally involved in an arteritis in systemic lupus erythematosus, thus mimicking Takayasu arteriopathy, which in its turn can, at its onset, be mistaken for systemic lupus erythematosus.
The heart -A pericardial rub, to fibrinous pericarditis, is heard in about half of the patients at one time or another. Pericarditis with effusion is rarer, but is nevertheless the commonest cause of an enlarged cardiac outline on the X-ray film in this condition.
The disease process can involve the heart muscle, with consequent rhythm changes, including auricular fibrillation and heart block. E.C.G. changes are therefore common (Brigden et al., 1960) . Such a patient, a woman of 47, was recently seen with cardiomegaly, congestive cardiac failure and an unexplained pyrexia, who worried us a lot diagnostically until a large number of L.E. cells was found in her blood. The response to steroids was dramatic, the high temperature fell at once and the cardiac size returned to normal.
The classical evidence of cardiac involvement is of the valves, which was described by Libman and Sacks as sterile verrucose endocarditis. The finding of heart murmurs resulting from valvular lesions is as important in differential diagnosis as in the natural history of the patient's illness, as it raises the possibility of the presence of sub-acute bacterial endocarditis, a condition that can mimic or accompany S.L.E. Hypertension, with or without renal involvement, can of course lead to cardiac enlargement.
RENAL LESIONS Transitory albuminuria, with an increase in the cellular deposit, is as commonly found in S.L.E. as in any febrile condition. The prognosis is, however, adversely affected in most cases to a very considerable degree when proteinuria persists, and a renal lesion becomes established. Of eight such patients I have studied in detail, three were dead within three years from the time of diagnosis, but two survived for eight and nine years. Three were still alive after ten, four and two years, respectively, but the last-mentioned was developing the signs of malignant hypertension, and had a blood urea of 102 mgm. per cent. Thus of the eight, only three are known, or are likely to have survived longer than five years from the time of diagnosis.
Gary and her associates (1967) have followed up eight patients with systemic lupus erythematosus with established renal lesions of more than thirty months duration. Four were initially in the nephrotic stage and two were azotaemic. All had the renal lesions of systemic lupus erythematosus proven by renal biopsy, and evaluated by strict criteria, such as the presence of haematoxylin bodies, and of widening and granularity of the glomerular capillary walls. This group of patients was observed to survive for periods ranging from 33 to 135 months without any evidence of progression of their renal lesions.
The policy with regard to steroid therapy adopted by Gary was to give sufficiently large doses of Prednisone to suppress the condition in the acute stages, and then to keep the dosage at the minimal level necessary to maintain the patient's renal function in an unprogressive state. This is a sensible approach provided one is prepared to err on the side of the high dosage rather than low dosage.
It seems that although the prognosis is much worse in those patients who are azotaemic or nephrotic, it is possible to survive with established renal lesions for a considerable period. A study by Comerford (1967) of the histology of the kidney in systemic lupus erythematosus, both by light and electron microscopy, has shown that there can be definite histological involvement without any clinical evidence of renal disease. He concluded:
(a) "There is considerable evidence that such injurious processes are related to primary abnormalities within the circulation, and that these, at least in part, are secondary to immune phenomena." (b) "It is probable that an important secondary mechanism of renal injury is related to intravascular coagulation, leading to the deposition of fibrinogenderived substances within the glomerulus, and the subsequent development of chronic renal damage and disease."
LUNGS AND PLEURA
The pleura, like the pericardium, is frequently involved in systemic lupus erythematosus, and recurring incidents of pleurisy should suggest the possibility that this is the underlying condition. The pleural space may become obliterated, and when an effusion is present L.E. cells may be found in the fluid. The commonest source of involvement of the lungs is, of course, bacterial, with bronchitis or pneumonia, as in any debilitating condition.
The radiological appearances of the lung fields are variable and have no special characteristics; miliary mottling may be seen, or there may be ill-defined infiltrations.
Interstitial pulmonary fibrosis, resembling primary interstitial pulmonary fibrosis, with either an acute or a prolonged clinical course, can occur with systemic lupus erythematosus. Both conditions have non-organ-specific auto-antibodies in the blood, but the titre for A.N.F. is low and L.E. cells are absent in primary interstitial pulmonary fibrosis, suggesting that they are separate conditions. When the lungs are involved in patients with S.L.E. the lesions may not be solely, or even partially due to this process, and the presence of a fungal infection must be sought with the greatest care when steroids are being used. The commonest fungus is Candida albicans, which can be respiratory or generalised, or occur at the site of any local infection, or in the gastro-intestinal or renal tracts. In a recent report (Pillay, 1968 ) the death of four patients was attributed to it, and it was considered to have contributed to the demise of eight others. In addition to candidiasis, aspergillosis, nocardiosis and coccidioidomycosis can complicate systemic lupus erythematosus, as of course can infection with Cryptococcus neoformans and the tubercle bacillus. The importance of keeping a watchful eye open for these infections is obvious.
THE LIVER There are several very important but unanswered questions concerning the liver and systemic lupus erythematosus. The liver is palpably enlarged in about a quarter of the patients, and it is histologically involved in a higher proportion. Clinical evidence of liver failure is nevertheless uncommon in patients with systemic lupus erythematosus.
L.E. cells are present in a variety of liver disorders without there being any evidence of systemic lupus erythematosus. They are found in some patients with virus hepatitis (hepatic lupus), and in a few with cirrhosis (lupoid hepatitis), where the prognosis is thought by some (MacKay and Wood, 1962) to be worse than in certain other types of chronic liver disease, such as alcoholic cirrhosis. The presence of L.E. cells in these various types of liver disease indicates an auto-immune process, but one which is in all probability secondary to tissue damage rather than of primary significance. Many authorities now consider that so-called lupoid hepatitis is essentially hepatitis with abnormal serological reactions rather than a part of systemic lupus erythematosus.
NEUROLOGICAL LESIONS Some neurological involvement in systemic lupus erythematosus is common, and authorities (Johnson and Richardson, 1968) have recently put the figure as high as 75 per cent. for involvement of the central nervous system, and at 8 per cent. for peripheral nerve involvement. Although lesions in the central nervous system account for a large number of deaths from this condition, just as in the case of renal lesions their presence does not invariably imply a bad prognosis. Their origin is usually from micro-infarcts in the cerebral cortex and brain-stem, and the serious clinical manifestations, in order of frequency, are convulsions, disturbance of mental function and signs referrable to the cranial nerves, but a wide variety of other central nervous system signs and symptoms may occur, including disorders of movement and of hypothalamic function (Honda, 1966) .
Involvement of the peripheral nervous system may take the form of a mononeuritis multiplex, thus imitating a carcinomatous neuropathy or polyarteritis nodosa, or the Guillain-Barre syndrome. The mononeuropathies are due to vascular lesions, but the symmetrical ones are more probably due to some abnormality of immunology rather than structural changes in the vessel walls.
The effectiveness or otherwise of steroids on these neurological manifestations is difficult to determine because they may recover spontaneously without any treatment at all. When convulsions or severe mental disturbances are present the therapeutic dilemma may be extremely taxing. It is of course well known that steroids can promote mental disorders, and indeed convulsions. On the other hand, schizophrenic reactions undoubtedly occur unrelated to the use of steroids, and there are several reports which claim therapeutic benefit from steroids in both affective and schizophrenic incidents. From examining case histories it seems clear that some people become psychotic shortly after the initiation of steroid therapy, and are relieved when the dosage is reduced or the treatment stopped, only to relapse when the previous dosage is restored. Others are relieved, or appear to be, by steroid therapy, and yet others recover without any.
The situation is even more anxious when the patient is experiencing a series of convulsions, or has developed status epilepticus. I personally find this a most difficult problem in the individual case, but my bias is towards increasing the dose of steroids unless they have been very recently instituted, in a patient previously free from all convulsions, on the grounds that if the fits are due to the decrease process, the patient's best hope is in suppressing it, whereas, if the fits are due to steroids, their mistaken continuation for a short time is the lesser of the two evils. Although aneleptic drugs will of course be used in most instances, it is important and rather frightening to remember that patients have developed systemic lupus erythematosus whilst receiving Hydantoin or Primodone for epilepsy.
PREGNANCY AND SYSTEMIC LuPus ERYTHEMATOSUS Acute systemic lupus erythematosus in pregnancy carries a high maternal mortality rate which, as a result of a review of reported cases (Turner et al., 1955 ) is put at between 20 and 60 per cent. for the mother, and 30 and 50 per cent. for the foetus. When systemic lupus erythematosus in the mother is sub-acute, she usually survives, but the foetal mortality is still high -about 40 per cent. Patients with discoid lupus erythematosus and no generalisation have not been observed to have any ill effects as a result of pregnancy.
The L.E. factor can pass the placental barrier and tests for it can remain positive for several weeks, or even two to three months in the child. Although there is virtually no risk to the child from this, it is obviously wise for a careful watch to be kept on the haematologic state of a child born of a mother with active systemic lupus erythematosus.
It has been suggested that women with systemic lupus erythematosus tend to have a reduced fertility, but Larson's figures (1961) do little to support this. He found that in the 62 patients of his who were of child-bearing age, there were 38 pregnancies. The present writer's experience has, however, been different, in that out of 31 women of child-bearing age recently studied, there were only 3 pregnancies. Two of these had abortions about the fifth month, and in both the systemic lupus erythematosus was exacerbated, in one with fatal results, whilst the other, who had had the disease for five years before her pregnancy but had previously only suffered from arthralgia, is now disfigured by her skin condition and disabled by arthritis.
The third woman, who first developed systemic lupus erythematosus at the fifth month, was delivered of a normal child, and has had no further symptoms. The child also has remained well. Blood from the umbilical cord showed antinuclear factor (A.N.F.) and L.E. cells, but neither were present some months later.
Only three of the 22 patients reported by Larson who had systemic lupus erythematosus before becoming pregnant were definitely worse during their pregnancy, but five had acute exacerbations shortly after delivery, and two women had an acute onset of the condition in the second trimester. None of the children who were born (22 out of 38 pregnancies) were abnormal, but there were 10 abortions and 6 stillbirths. It seems that there is a real risk to the mother during pregnancy if systemic lupus erythematosus is active, and that there is a high incidence of abortion or miscarriages once the disease is disseminated (Richardson, 1963) . PROGNOSIS The discoid type of lupus erythematosus may remain ungeneralised and benign indefinitely, although the skin lesions themselves persist in about half of the patients. They can, nevertheless, disappear with little or no residual change. Generalisation, however, occurs in about 10 per cent. of patients (Ingram, 1960) , and may alter the whole course of the illness, and with it the prognosis.
Systemic lupus erythematosus is a dangerous disease and even when the course is benign, it rarely disappears entirely, although occasional examples are on record. Dubois (1956) found the mean duration of the illness in patients untreated by steroids was two years, and 80 per cent. of Hill's (1957) patients were dead in five years. In series in which the follow up has been prolonged, more encouraging figures have been recorded. Rupe and Nickel (1959) found that half of their patients were alive at the end of 10 years, and Richardson (1965) one-third of his. One of Rupe and Nickel's patients was alive 34 years from the onset, and two of Richardson's over 25 years.
The type of onset affects the prognosis, and those with an acute onset have a worse prognosis than those in whom it is insidious. The subsequent course of the disease may be relatively benign with a good prognosis in respect of survival. Onethird are alive after 10 years from the onset, and have little serious disability; 66 per cent. of the surviving patients find life, at the worst, tolerable, and half of my series regard themselves as well.
A more malignant course with a bad prognosis in respect of life and disability must be feared under certain circumstances. The prognosis is particularly bad in women during the reproductive period of their lives. It is often, like all other diseases of the connective tissue, severely worsened by renal involvement. This however, is not invariably the case, but the earlier a renal lesion occurs in the course of the illness, the worse is its prognostic significance. Widespread arteritis or involvement of the blood-forming organs, with consequent haemolytic reactions, neutropenia or thrombocytopenia, are usually sinister, but both thrombocytopenia with purpura and a haemolytic anaemia can be present for years before a fatal outcome supervenes, or indeed evidence of systemic lupus erythernatosus develops.
TREATMENT
There is no specific treatment for systemic lupus erythematosus, but corticosteroids undoubtedly have a very large place in the management of these patients. When an adequate dosage is given, the temperature in acutely ill patients begins to return to normal in the majority of instances within 48 hours. Pains in joints and muscles reduce and the general sense of illness diminishes. Skin lesions, serious effusions, glandular and organ enlargements are slower to improve, and the response may be only partial. If anaemia, due to haemolysis, is present, it is soon brought under control and the Coombs' test becomes negative .The number of L.E. cells in the blood is reduced, the E.S.R. diminishes, as does the raised level of the gamma globulins, and the biological false positive W.R. becomes negative.
The immediate outlook for the patient is largely determined by the initial response to full doses of steroids, while the long-term prognosis depends greatly on the ability to control the activity of the disease with small doses, i. Chloroquin is usually given in divided dosage, with a total of 150-300 mgm. of base daily. It has a good effect on the rash of lupus erythematosus, but much less on the generalised manifestations. Its mode of action is unknown, but its toxic effects are well recognised. They include nausea, vomiting and headache, bleaching of the hair, and important ocular complications. Transitory difficulty in accommodation and corneal opacities tend to disappear when the drug is withdrawn, but a retinopathy somewhat resembling retinitis pigmentosa may persist.
Valuable as steroids and A.C.T.H. undoubtedly can be in the management of patients with systemic lupus erythematosus, they in no sense provide a complete therapeutic answer, and thus other measures are always being sought.
Antimetabolites are undergoing appraisal at the present time. The theory is that if antibody is produced by actively growing lines of lymphocytes which are especially vulnerable to the action of purine antagonists, these drugs might have an immunosuppressive effect. Although their mode of action is not fully understood, 6-thioguanine (6-T.G.), 6-mercaptoprine (6-M.P.) or one of its derivatives azathioprine, partially block the production of humoral circulatory antibodies, and, unlike cortisone, have some effect on delayed or cellular type of hypersensitivity (Corley et al., 1966) . Such clinical benefits as have occurred have been mostly in patients with renal lesions, but in some instances the rashes, fever and arthralgia of systemic lupus erythematosus have been improved even when steroids were not being given in combination with the antimetabolite.
The dosage is critical, since if more than a purely temporary result is to be achieved, enough must be given to threaten some degree of marrow depression. It may be between 1.25 mgm. to 2.5 mgm. per kilo per day, but must be determined for each individual patient and be controlled by frequent blood counts. The actual preparation chosen will depend upon the physician's experience, but azothioprine has been shown to be considerably more immuno-suppressive in animals and man than its parent substance 6-mercaptoprine (Steiner and Nabrady, 1965) . The possibility that the combination of prednisone with an azothioprine preparation may allow the later to be effective in non-toxic doses is being explored.
Before concluding, two points by way of prophylaxic must be made. Patients with systemic lupus erythematosus are often extremely sensitive to drugs, and great caution must be exercised in their use in these people. No drug whatsoever, and this includes immunising agents, should be given without very careful thought.
Finally, these patients are sun-sensitive, and should be instructed to use an efficient barrier cream, even if exposure to the sun is expected to be for only a matter of minutes. Homely advice, but a good note on which to end.
